O-GlcNAcylation in the osteoblast lineage-boosting the complexity of Wnt-stimulated bone formation
Standard
O-GlcNAcylation in the osteoblast lineage-boosting the complexity of Wnt-stimulated bone formation. / Pohl, Sandra; Schinke, Thorsten.
in: EMBO REP, Jahrgang 25, Nr. 10, 10.2024, S. 4110-4112.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - O-GlcNAcylation in the osteoblast lineage-boosting the complexity of Wnt-stimulated bone formation
AU - Pohl, Sandra
AU - Schinke, Thorsten
PY - 2024/10
Y1 - 2024/10
N2 - Although differentiation and activity of bone-forming osteoblasts are regulated at various levels, there is ample evidence that components of the Wnt signaling pathway play a dominant role in bone mass acquisition. Moreover, a neutralizing antibody blocking the Wnt signaling inhibitor sclerostin has recently been established as a novel osteoanabolic treatment option for osteoporotic patients. Importantly, however, the molecular mechanisms explaining the osteogenic influence of Wnt molecules are still not fully clarified. In this issue of EMBO Reports, You and co-workers show that O-GlcNAcylation is required for the osteoanabolic effect of Wnt stimulation, in vitro and in vivo (You et al, 2024).
AB - Although differentiation and activity of bone-forming osteoblasts are regulated at various levels, there is ample evidence that components of the Wnt signaling pathway play a dominant role in bone mass acquisition. Moreover, a neutralizing antibody blocking the Wnt signaling inhibitor sclerostin has recently been established as a novel osteoanabolic treatment option for osteoporotic patients. Importantly, however, the molecular mechanisms explaining the osteogenic influence of Wnt molecules are still not fully clarified. In this issue of EMBO Reports, You and co-workers show that O-GlcNAcylation is required for the osteoanabolic effect of Wnt stimulation, in vitro and in vivo (You et al, 2024).
U2 - 10.1038/s44319-024-00242-2
DO - 10.1038/s44319-024-00242-2
M3 - SCORING: Journal article
C2 - 39256594
VL - 25
SP - 4110
EP - 4112
JO - EMBO REP
JF - EMBO REP
SN - 1469-221X
IS - 10
ER -